ArticleJMIR rehabilitation and assistive technologies2026
Smartphone-Based Grading and Rehabilitation in Patients With Facial Palsy Using Computer Vision: Prospective Validation Study.
Article in JMIR rehabilitation and assistive technologies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Peripheral facial palsy causes significant functional and psychosocial impairments, requiring precise assessment and patient engagement for effective rehabilitation. However, conventional clinician-graded scales (eg, House-Brackmann Scale, Sunnybrook Facial Grading System, and Stennert Index) are subjective and prone to interobserver variability, limiting their reliability for tracking recovery. Smartphone-based computer vision solutions offer objective, standardized facial movement grading, and interactive home-based training to improve adherence and outcomes. Objective: This pilot study evaluated a novel iOS smartphone app (Apple Inc.) for facial palsy management. The app uses the iPhone TrueDepth 3D camera and on-device computer vision to compute a Digital Facial Index (DFI) for objective facial movement analysis, and provides guided neuromuscular facial exercises with real-time biofeedback. The study aimed to validate DFI against standard clinical grading scales and assess patient-reported outcomes and usability. Methods: A 4-week single-arm pilot included 21 patients with unilateral facial palsy. Participants used the app at home for daily facial exercises and periodic self-assessments with DFI. Clinicians, blinded to DFI, rated facial function from standardized video exams at baseline and 4 weeks using the House-Brackmann Scale, the Sunnybrook Facial Grading System, and the Stennert Index. DFI concurrent validity was evaluated via correlation with these clinician scores. Patient-reported outcomes included pre- and postintervention Facial Disability Index (FDI) physical and social scores, the System Usability Scale, and a poststudy user feedback questionnaire. Results: During the study period, strong correlations were observed between DFI and conventional clinical scores. FDI physical and social showed significant functional improvement. Mean System Usability Scale was 88.3 (SD 15.4), indicating excellent usability, and participants reported high satisfaction, preferring the app over traditional paper-based exercises. Conclusions: The app's DFI provided objective facial function grading that correlated well with standard clinical scales. Patients' FDI scores improved significantly over 4 weeks. High usability and patient preference support the app's feasibility for home-based rehabilitation. This digital approach is promising for facial palsy management, and controlled studies are needed to confirm efficacy and improve long-term engagement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.